Patents by Inventor Anders Brunsvik

Anders Brunsvik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8839962
    Abstract: The present invention concerns a method for separation of the antifungal cyclic hexapeptides Pneumocandin B0 from Pneumocandin C0 using a hydrophilic stationary phase and a hydrophobic mobile phase.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: September 23, 2014
    Assignee: Xellia Pharmaceuticals APS
    Inventor: Anders Brunsvik
  • Patent number: 8492707
    Abstract: The present invention concerns a method of detecting the antifungal cyclic hexapeptides Pneumocandin B0 and/or Pneumocandin C0 specific fragment is/are detected using MS in negative mode.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: July 23, 2013
    Assignee: Xellia Pharmaceuticals APS
    Inventors: Anders Brunsvik, Martin Mansson
  • Publication number: 20120138786
    Abstract: The present invention concerns a method of detecting the antifungal cyclic hexapeptides Pneumocandin B0 and/or Pneumocandin C0 specific fragment is/are detected using MS in negative mode.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 7, 2012
    Applicant: XELLIA PHARMACEUTICALS APS
    Inventors: Anders Brunsvik, Martin Mansson
  • Publication number: 20120142893
    Abstract: The present invention concerns a method for separation of the antifungal cyclic hexapeptides Pneumocandin B0 from Pneumocandin C0 using a hydrophilic stationary phase and a hydrophobic mobile phase.
    Type: Application
    Filed: August 11, 2010
    Publication date: June 7, 2012
    Applicant: Xellia Pharmaceuticals ApS
    Inventor: Anders Brunsvik